Riskpilot← Back to searchSign inGet full accessAcinomia AB
ABDissolvedOrg 5561644278LundAccounting, bookkeeping and auditing activities; tax consultancy · NACE 6920Est. 19720 employees
Revenue 2024
SEK -119K
-106% vs 2023
EBITDA margin
196.6%
-118% vs 2023
Equity ratio
87.7%
Financial strength
Net profit 2024
SEK -88K
-108% vs 2023
| Revenue | SEK -119K | -106% |
| EBITDA | SEK -234K | -118% |
| Net profit | SEK -88K | -108% |
| Total assets | SEK 4,2M | -16% |
| Equity | SEK 3,6M | -2% |
| Employees | 0 | — |
Legal name
Acinomia AB
Org number
5561644278
Legal form
Aktiebolag
NACE code
6920 · Accounting, bookkeeping and auditing activities; tax consultancy
Founded
24 maj 1972
Share capital
SEK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanterna
Company purpose
Bolaget skall bedriva redovisningsbyrå och därmed förenlig verksamhet.
Address
Lund
Phone
+468806230
Email
info@bolagspartner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 936 | — | 1 431 | 1 837 | −119 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 581 | 0 | 149 | 1 315 | −234 |
| Depreciation & amort. | −16 | — | −0 | −0 | −0 |
| EBIT | 565 | 0 | 149 | 1 315 | −234 |
| Net financials | −1 | — | −5 | 101 | −5 |
| Profit before tax | 413 | 0 | 505 | 1 415 | −88 |
| Tax | −100 | — | −115 | −327 | −0 |
| Net profit | 313 | — | 390 | 1 088 | −88 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 469 | — | 4 504 | 4 964 | 4 152 |
| Equity | 2 084 | — | 2 643 | 3 730 | 3 642 |
| Long-term debt | 1 491 | — | 555 | 0 | 0 |
| Short-term debt | 385 | — | 1 156 | 1 084 | 510 |
| Total debt | 1 876 | — | 1 711 | 1 084 | 510 |
EBITDA margin
-23400000.0%
This company
15.8%
Market median
-148101366% vs market
20202024
Equity ratio
87.7%
This company
38.2%
Market median
+130% vs market
20202024
Return on equity
-2.4%
This company
18.4%
Market median
-113% vs market
20202024
Net profit margin
-8800000.0%
This company
8.1%
Market median
-108642075% vs market
20202024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Acinomia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kenneth Stig Rolf Karlsson | Deputy Board Member | 0 companies |
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Karl-Johan Staffan Tångby | Board of Directors | 0 companies |
| Monika Rose-Marie Lindberg | Board of Directors | 0 companies |
| Alexander Joe Friberg | Board of Directors | 0 companies |